Zealand Pharma A/S (OP: ZLDPF )

121.72 +2.68 (+2.25%)

Streaming Delayed Price Updated: 12:39 PM EST, Nov 8, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	475
Open	123.41
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	119.04
Today's Range	121.72 - 123.41
52wk Range	40.40 - 141.74
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names

October 11, 2024

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

Via Benzinga

International Small-Cap ETF Reaches 52-Week High, Leaving Investors Wondering What's Next

August 22, 2024

SCZ, an ETF tracking small-caps outside of NA, hits 52-wk high at $65.60. Strong performance of top holdings and bullish trends point to continued success.

Via Benzinga

Performance

YTD	+132.51%	+132.51%
1 Month	+3.50%	+3.50%
3 Month	-3.19%	-3.19%
6 Month	+35.62%	+35.62%
1 Year	+201.29%	+201.29%

More News

Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss

June 21, 2024

Via Benzinga

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF

May 28, 2024

Via InvestorPlace

Obesity Drug Achieves ~15% Weight Loss - Zealand Pharma-Boehringer Ingelheim Partnered Drug May Compete With Novo Nordisk, Eli Lilly

May 10, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

March 11, 2022

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.